I disagree. Let's look at the last 3 crucial weeks:
6th May: PHE very concerned about B.1.617.2 & about to make a VoC. Report delayed because of local elections, pubished 7 May. PHE bounced into announcement by Guardian & Channel 4 coverage.
13th May: Report was ready on Thursday afternoon with a page on schools data (seen by Observer) - report published hours later in the evening with just the schools page removed.
Observer has seen evidence this removal was at Num 10 request. theguardian.com/world/2021/may… 2/5
20th May: PHE told journalists report would be released on Thursday (when it was due). it was not. Then Friday lunchtime - it was not. Then Friday sometime. It was not.
Finally released Sat night - no press release (unlike vax report released at same time). No school data. 3/5
*If* this was just difficulty issue then wait till Sunday, release it *with a press briefing* and explain to the public what is in it.
Or is it suddenly not news that B.1.617.2 is now "high risk" for transmissibilty & vax escape AND likely dominant in England? 4/5
This is politics not public health and it's not OK. /END
SHORT THREAD ON SCHOOLS:
As we open up, schools are becoming the biggest places where large groups of unvaccinated people mix.
This makes them more vulnerable to outbreaks if local cases increase.
But data on what is happening in schools is sparse.
Firstly, twice weekly lateral flow device tests (LFDs) - the government's main mitigation in secondary schools now that they've removed masks - are not really being done.
There should be about 8 million LFDs a week in secondary schools. But we are only seeing 2 million.
Numbers picked up a bit after Easter holidays but are now back to where they were in mid April & at ~25% of expected tests (and that's not counting school staff)
Regardless of how effective an intervention it is, this is the government's main strategy. And it's not being done.
THREAD: I know many people are thinking "but how can this new variant be scary when overall case numbers are flat?"
Here's how.
(Numbers that follow are illustrative but based on case data & sequenced proportion data from Sanger: covid19.sanger.ac.uk/downloads) 1/6
Cases of B117 ("Kent") variant have been falling every week, while cases of B.1.617.2 (1st sequenced in India) have been growing. Total cases are B117+B.1.617.2.
We've had two epidemics at once. During early days for B.1.617.2, its growth is entirely masked by fall in B117 2/6
As proportion of cases that are new variant grows, overall cases start to creep up - but not by much. Not at first.
In this example, it's an 11% increase week ending 22nd May. 3/6
THREAD on vax study for B.1.617.2 (new "Indian" variant):
@jburnmurdoch broke a story from PHE data with the first real world analysis of AZ & Pfizer vaccine efficacy against B.1.617.2.
I am less convinced this is great news than some. Here's why. ft.com/content/a70d42… 1/16
The study estimates that both vaccines are 33% at preventing symptomatic B.1.617.2 disease after 1 dose (vs 51% against B117 ("Kent")) and 81% effective after 2 doses (vs 87% for B117).
Too little data on preventing severe disease to say much but v likely to be better. 2/16
So the vaccines do mostly work against B.1.617.2 - especially after 2 doses. That's good news - but not surprising.
We already had evidence from a care home outbreak, & Bolton hospital. Early lab studies suggested less escape than B.1351 "S Africa" blogs.bmj.com/bmj/2021/05/18… 3/16